Bauer, who has a PhD in neuroscience and endocrinology, joins Geller to discuss insulin resistance and the shame many women feel about their weight.
Recap by typeshit. Post by @jamiegeller on Instagram.
She talks with Annika Urban about combining GLP-1 treatment with behavioral coaching and telehealth care.
An opinion piece drawing on Sabrina Strings to tie GLP-1 culture, celebrity ads and Ozempic-friendly menus to class and belonging.
Oddo moved to DKK 305 and HSBC to DKK 280. Novo also shared a CagriSema subgroup analysis showing women lost 25% of body weight at 68 weeks.
MUSC Health suggests the familiar ABCs of heart health may change, with GLP-1 medications now part of cardiovascular prevention for some patients.
Led by Alabama's Steve Marshall, the AGs call the supply chain a security risk and say an FDA import list could be used to launder knock-off semaglutide.
Novo says results held across menopausal stages among 1,900 women, from 23.1% to 26.7%, against about 2% on placebo. The piece also pitches obesity ETFs.
Loading…